A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists

Similar documents
Wifi classification does not predict limb amputation risk in dialysis patients following critical limb ischemia revascularization

3-year results of the OLIVE registry:

PATIENT SPECIFIC STRATEGIES IN CRITICAL LIMB ISCHEMIA. Dr. Manar Trab Consultant Vascular Surgeon European Vascular Clinic DMCC Dubai, UAE

A new classification of the diabetic ischaemic foot promotes a modern approach to treatment. Michael Edmonds King s College Hospital London

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

Multisciplinary Team and Diabetic Foot Syndrome

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Hybrid surgical treatment of bilateral aorto-femoral occlusion: a clinical case

Update from Korea on the Lutonix SFA registry 12 month data

Nurse and Technician Forum Part II Critical Limb Ischemia: Optimal care, an interdisciplinary challenge

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

Shockwave Medical Lithoplasty. Thomas Zeller MD Universitäts-Herzzentrum Freiburg & Bad Krozingen, Germany

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

Endovascular treatment of severe TASC C and D external iliac artery occlusive disease. SAINT-LEBES Bertrand Toulouse FRANCE

Multidisciplinary approach to BTK Y. Gouëffic, MD, PhD

Takayasu disease Is it still a room for intervention? NO YES. BUT

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions Preliminary report

CRITICAL LIMB ISCHEMIA UNITED STATES EPIDEMIOLOGY TABLE OF CONTENTS

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry

The Role of Lithotripsy in Solving the Challenges of Vascular Calcium. Thomas Zeller, MD

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

The results of EVT for Chronic Aortic Occlusion - a multicenter retrospective study - Taku Kato, MD Rakuwakai Otowa Hospital, Kyoto, Japan

Drug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience

The ZILVERPASS study a randomized study comparing ZILVER PTX stenting with Bypass in femoropopliteal lesions

Successful endovascular treatment using biopsy forceps for iliac artery stenosis with an organized thrombus

Aortic surgery education Germany

Objective assessment of CLI patients Hemodynamic parameters

6/12/2014. Peripheral Arterial Disease US Population. Defining CLI and the Scope of the Problem. Defining CLI and the Scope of the Problem

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller

How do I use mechanical debulking for the treatment of arterial occlusions

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions

BIOLUX P-III Passeo-18 Lux All-comers Registry: 12-month Results for the All-Comers Cohort

CLI Therapy- LINCed Multi disciplinary discussions on CLI

Introduction. Risk factors of PVD 5/8/2017

Evolution of gender-related differences in outcome of EVAR

Peripheral Vascular Disease

The Fate of Unexpected Events Occurring in Standard EVAR

ILLUMENATE FIH Direct DCB Cohort 12-Month Results

Long-term Zilver PTX Data from Japan: 5-year Results in the Real World

Maximizing Outcomes in a complex population with Drug-coated balloon

Revascularisation for Claudication: When is it indicated, when not? Markus Haumer Landesklinikum Baden-Mödling Austria

PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI

Hybrid Procedures for Peripheral Obstructive Disease - Step by Step -

HYPOGASTRIC ARTERY PRESERVATION DURING EVAR: SURGICAL AND ENDOVASCULAR TECHNIQUES Single Centre Experience. Ilaria Ficarelli

Importance of Thorough Vessel Preparation Followed By Anti- Restenotic Therapy: An Update from the DEFINITIVE AR Study

OMNIA case results: Lumee Oxygen measurements representative for CLI wound healing prognosis. M Werner 1 Feb 2018

XPEDITE Clinical Study PaclitaXel-coated Peripheral StEnts used In the Treatment of FemoropoplitEal Stenoses

Comparing endoluminal bypass to open fem-pop bypasses; Final 1-year results of the SUPERB trial

Evolving Challenges in the Evaluation and Treatment of Lower Extremity PAD -- The Peripheral Academic Research Consortium (PARC)

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 24-Month Results

Anatomical applicability of current off-the-shelf branched endografts in thoracoabdominal aortic aneurysms managed by open surgery.

SANGER HEART & VASCULAR INSTITUTE

DETECT-PAD Computerized and patient specific model to determine pressure gradients in borderline iliac artery stenosis with MRA/ CTA

Novel distal popliteal artery puncture technique in supine position for chronic femoropopliteal arterial occlusion; frontal popliteal puncture

Preliminary 6-month results of VMI-CFA trial

Angiosome concept myth or truth? Does it make a real difference in real world cases?

2 Year Results from the MDT SFA Japan Trial - DCB vs. standard PTA for the treatment of atherosclerotic lesions in the SFA/PPA

Registry Assessment of Peripheral Interventional Devices (RAPID)

DECLARATION OF CONFLICT OF. No conflict INTEREST

Catheter-Directed Thrombolysis for Acute Limb Ischemia. Hwan Jun Jae MD Seoul National University Hospital Seoul, Korea

Limb Salvage in Diabetic Ischemic Foot. Kritaya Kritayakirana, MD, FACS Assistant Professor Chulalongkorn University April 30, 2017

Extreme SFA Lesions: DETOUR I 12- Month Results in Lesions >30cm. Sean Lyden, MD Chairman Vascular Surgery Cleveland Clinic Cleveland, Ohio

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Adventitial Drug Therapy Below-the-Knee: Update on LIMBO and TANGO

Is there enough evidence for DAPT after endovascular intervention for PAOD?

OCT Guided Atherectomy: Initial Results of the VISION Trial Using the Pantheris Catheter. Patrick Muck, MD

PRISM Trial. Retrospective Case Review of Technical Success Using the Penumbra and Indigo Systems for Mechanical Thrombectomy in the Periphery

SFA CTO Lesion Management laser or directional atherectomy?

The Supera stent In retrograde vascular access for SFA ostium treatment: The SUPRA-FAST Registry

Vascular complications after extracorporeal membrane oxygenation (ECMO) Alessandro Grandi

A Healthy Heart. IN BRIEF: Your Guide to

Vascular screening in diabetic patients: how aggressive should we be and when to intervene?

Surgical Bypass vs. Zilver PTX stent for long SFA lesions : Interim results of the ZilverPass Trial

Six Month Results of the Global BIOLUX P-III All-Comers Registry using Drug Coated Balloon in Infra-Inguinal Artery Disease

Disclosure. I do not have any potential conflict of interest

Klinikum Rosenheim Department of Diagnostic and Interventional Radiology

SAVE LIMBS SAVE LIVES!

Peripheral Arterial Disease (PAD): Presentation, Diagnosis, and Treatment

The TANGO Trial: A phase II below-the-knee study investigating the adventitial micro-infusion of Temsirolimus after PTA or atherectomy

Successful transcollateral approach for chronic total occlusion of the superficial femoral artery using a side-hole sheath

The latest evidences from the DES trials in peripheral arterial disease

Clinical benefits on DES Patient s perspectives

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

Adventitial Drug Therapy for Critical Limb Ischemia

Endovascular Should Be Considered First Line Therapy

CHALLENGING ILIAC ACCESSES AND THROMBOSIS PREVENTION

Clinical Outcomes of Pedal Artery Angioplasty for Patients with Ischemic Wounds Result from the Multicenter RENDEZVOUS Registry

Study of a Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery

LIBERTY 360 Study. 15-Jun-2018 Data 1. Olinic Dm, et al. Int Angiol. 2018;37:

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease?

The clinical outcome camparison between covered stent(cv) and drug-eluting balloon(deb) for SFA lesions: a single center result

World s Fastest Ankle-Brachial Index Screening Device

Transcription:

A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists Ana Paula Mollón MD Hospital Nacional A. Posadas Argentina

Disclosure Speaker s name: Ana Paula Mollon I have the following potential conflicts of interest to report: Consulting Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) x I do not have any potential conflict of interest

Multidisciplinary team creation: Background Peripheral vascular disease has a high prevalence (1 out of 5 patients over 65 suffer from this disease). The probable reasons are the incipient epidemic of diabetes, obesity and advanced age and the increasing prevalence of atherosclerosis. However this disease is underdiagnosed and undertreated, and leads to inadequate care and delayed treatment.

Argentina is not an exception Inadequate awareness of the disease among physicians and patients. Poor coordination between cardiologists and vascular specialists (Interventional cardiologists and vascular surgeons). High major amputation rates. Inefficient method to ensure the followup.

A change was needed We focused on two main strategies: 1. Improving diagnosis: We have increased the awareness of vascular disease among generalists and cardiologists through seminars, meetings and other targeted educational efforts. We have developed a screening program. 2. Creating a multidisciplinary team : We have provided an integral and continuum care instead of giving only endovascular treatment and eventually we have optimized the final

Improving the diagnosis: Cardiologist s role Implementing a screening program among the population to identify risk patients. According to the guidelines, they are defined as older than 70 years or over 50 years with history of diabetes or smokers. They have been evaluated using:! Who/Rose questionnaire! Examination of the pulses in the lower limbs! Ankle-Braquial Index.

Fist step: a quick evaluation

Improving Cardiologist s role in diagnosis Peripheral disease patients share the same risk factors, medical management and principles of revascularization as cardiovascular patients. Cardiologists should be aware and able to be the first to diagnose peripheral arteries diseases. Long-term prognosis of patients who suffer from lower extremity arterial disease will be determined by the presence and extent of associated coronary artery disease. Cardiologists should play a key role in the diagnosis and follow-up.

Multidisciplinary team Our team is formed by vascular surgeons, generalists, cardiologists, interventional cardiologists, diabetic specialists, orthopedic surgeons and infectious disease specialists. Each discipline participates in the decisions about the treatment according to its own perspective. We are optimizing a coordinated treatment and personalized follow-up.

2000 1500 1000 500 0 Results in our hospital Diagnosis Treatment Increase in the number of patients (35% in endovascular treatment). Clinical charateristics Rutherford 3 Rutherford 4 Rutherford 5 Rutherford 6 Significant increase in treatment of patients with intermittent claudication (30%) Decrease in major amputation rate (6%) 30 20 10 0 2012-2013 2014-2015

Take-home message Cardiologists should play a leading role in the diagnosis and follow-up. Multidisciplinary teams introduce a new integral vision to treat this disease. The team has been able to build bridges and break interdisciplinary barriers so as to create an effective horizontal integration, allowing a complete management of these patients. Every effort should be made to minimize amputation rates.

Thank you for your attention!!

A multidisciplinary team approach for vascular disease: The role of cardiologists and vascular specialists Ana Paula Mollón MD Hospital Nacional A. Posadas Argentina